Translational Regenerative Therapies for Chronic Spinal Cord Injury
Open Access
- 15 June 2018
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (6) , 1776
Abstract
Spinal cord injury is a chronic and debilitating neurological condition that is currently being managed symptomatically with no real therapeutic strategies available. Even though there is no consensus on the best time to start interventions, the chronic phase is definitely the most stable target in order to determine whether a therapy can effectively restore neurological function. The advancements of nanoscience and stem cell technology, combined with the powerful, novel neuroimaging modalities that have arisen can now accelerate the path of promising novel therapeutic strategies from bench to bedside. Several types of stem cells have reached up to clinical trials phase II, including adult neural stem cells, human spinal cord stem cells, olfactory ensheathing cells, autologous Schwann cells, umbilical cord blood-derived mononuclear cells, adult mesenchymal cells, and autologous bone-marrow-derived stem cells. There also have been combinations of different molecular therapies; these have been either alone or combined with supportive scaffolds with nanostructures to facilitate favorable cell–material interactions. The results already show promise but it will take some coordinated actions in order to develop a proper step-by-step approach to solve impactful problems with neural repair.Keywords
This publication has 74 references indexed in Scilit:
- Pushing the science forward: chitosan nanoparticles and functional repair of CNS tissue after spinal cord injuryJournal of Biological Engineering, 2013
- The Effect of Umbilical Cord Blood Cells on Outcomes After Experimental Traumatic Spinal Cord InjurySpine, 2010
- Neuronal Apoptosis Is Inhibited by Cord Blood Stem Cells after Spinal Cord InjuryJournal of Neurotrauma, 2009
- Combined Intrinsic and Extrinsic Neuronal Mechanisms Facilitate Bridging Axonal Regeneration One Year after Spinal Cord InjuryNeuron, 2009
- Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patientsSpinal Cord, 2009
- The Effects of Soluble Growth Factors on Embryonic Stem Cell Differentiation Inside of Fibrin ScaffoldsStem Cells, 2007
- Extensive Neuronal Differentiation of Human Neural Stem Cell Grafts in Adult Rat Spinal CordPLOS Medicine, 2007
- Axonal Remyelination by Cord Blood Stem Cells after Spinal Cord InjuryJournal of Neurotrauma, 2007
- The long-term neurocompatibility of human fibrin sealant and equine collagen as biomatrices in experimental spinal cord injuryExperimental and Toxicologic Pathology, 2007
- Nerve Anastomosis with Glue: Comparative Histologic Study of Fibrin and Cyanoacrylate GlueJournal of Reconstructive Microsurgery, 2003